Trixeo Aerosphere

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instance_of gptkb:fragrance
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:temple
gptkbp:appointed_by inhalation
gptkbp:approves gptkb:FDA
gptkbp:availability prescription only
gptkbp:class gptkb:physicist
anticholinergic
long-acting beta agonist
gptkbp:clinical_trial gptkb:TRIBUTE_study
Phase III
COPD management
REACH study
PIVOTAL study
long-term control of asthma
gptkbp:contains gptkb:glycopyrrolate
gptkb:budesonide
gptkb:formoterol
gptkbp:contraindication hypersensitivity to components
gptkbp:dosage_form gptkb:superhero
gptkbp:form aerosol
https://www.w3.org/2000/01/rdf-schema#label Trixeo Aerosphere
gptkbp:indication maintenance treatment
gptkbp:ingredients gptkb:glycopyrrolate
gptkb:budesonide
gptkb:formoterol_fumarate
gptkbp:interacts_with diuretics
beta-blockers
CY P3 A4 inhibitors
gptkbp:is_used_for gptkb:asthma
chronic obstructive pulmonary disease
gptkbp:label patient information leaflet
black box warning
prescribing information
gptkbp:manager inhalation
gptkbp:manufacturer gptkb:temple
gptkbp:marketed_as gptkb:2021
gptkbp:packaging pressurized canister
gptkbp:population adults
children over 12
gptkbp:previous_name gptkb:budesonide/formoterol/glycopyrrolate
gptkbp:price varies by insurance
gptkbp:safety_features monitor for adrenal insufficiency
not recommended for acute attacks
potential for cardiovascular effects
risk of pneumonia
gptkbp:side_effect dizziness
headache
nausea
cough
thrush
gptkbp:storage room temperature